Last December, Invitrogen CEO Greg Lucier told analysts to "think India for research."

Clearly, Invitrogen is. The Carlsbad, Calif., company has named Uday Matrubutham, a senior scientist of Indian extraction, as associate director of R&D. He has moved to Bangalore to manage a research and development facility that is expected to become operational this month. The facility will employ 20 scientists for research in functional genomics and bioinformatics, the company said. Further details were not available.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.